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Abstract: Biofilms are assemblages of bacterial cells irreversibly associated with a surface where
moisture is present. In particular, they retain a relevant impact on public health since through
biofilms bacteria are able to survive and populate biomedical devices causing severe nosocomial
infections that are generally resistant to antimicrobial agents. Therefore, controlling biofilm formation
is a mandatory feature during medical device manufacturing and during their use. In this
study, combining a crystal violet staining together with advanced stereomicroscopy, we report
an alternative rapid protocol for both qualitative and semi-quantitative biofilm determination having
high specificity, high repeatability, and low variability. The suggested approach represents a reliable
and versatile method to detect, monitor, and measure biofilm colonization by an easy, more affordable,
and reproducible method.
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1. Introduction
Biofilms are organized layers of Gram-positive and Gram-negative bacteria attaching to both
abiotic and biotic surfaces [1,2]. They can colonize metal surface of medical devices such as heart
valves, pacemakers, and catheters [3] adversely affecting their functions and causing severe nosocomial
infections [4]. According to a report by the Italian Institute of Health, most infections are caused by
biofilms formation [5]. Examples of biofilm-associated medical conditions are indwelling devices,
dental plaque, upper respiratory tract infections, peritonitis, and urogenital infections often associated
with an increased resistance to antimicrobial agents [6]. Antimicrobial resistance has a relevant
impact on healthcare since infected individuals require longer hospitalization often associated with
a poor prognosis [7]. Chemical agents or biocides can be used to sterilize metal surfaces. However,
these preventive treatments are not sufficient to control biofilm formations [8]. Bacteria growing in
biofilms are difficult to eradicate due to a combination of a protective sheets and for the intrinsic
antibiotic resistance of involved strains [9]. There is a wide range of tests that are currently used
for biofilm detection such as DNA based methods (PCR, DNA sequencing), imaging (confocal
scanning laser microscopy with molecular probes, Fluorescence In Situ Hybridization (FISH) or
labelled antibodies-electron microscopy) and others [10–12]. However, these methods can show
several limitations. First, most biofilms on medical devices are due to a polymicrobial contamination,
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thus tests on a limited range of bacterial strains may not be sufficient [13]. Furthermore, there are still
no biomarkers able to specifically identify a growing mixed bacteria population. A possibility could be
the detachment of biofilms from the biomaterial for further profiling, however this may prevent the
identification of the peculiar geometry and shape that can facilitate bacteria proliferation and biofilm
formation. Moreover, some detection methods require large and expensive laboratory equipment and
several days or weeks to perform the analyses [14].
Today, medical device manufacturers are more frequently involved in finding more reliable
techniques for detecting, measuring, and controlling biofilm formation. The aim of this study
is to propose a predictive method to screen biofilms on new materials during biomedical device
manufacturing and testing. This alternative ex vivo platform might discriminate the “bio-adhesive
properties” of different materials based on the presence/absence of a staining, allowing qualitative and
semi-quantitative read-outs to be then combined with additional molecular and in vivo investigations.
This new platform could be advantageous for manufacturers in order to perform a large-scale screening
of materials and during the R&D (Research and Development) phase, before selecting the most
suitable material. Moreover, this method could find space within a hospital environment for early
biofilm detection.
2. Materials and Methods
The experimental approach was based on four phases: (1) bacterial culture and biofilm preparation;
(2) crystal violet staining of biofilm populated stainless steel welded heat-exchangers; (3) detection
of the biofilm by stereo microscopic qualitative analysis; and (4) measurement of biofilm populating
material by semi-quantitative analysis.
Bacterial culture media and biofilm preparation. As suggested by IEC (International
Electrotechnical Commission) 60601-2-16 [15], a mix of four types of bacteria strains commonly
populating medical devices was introduced: Gram-positive, aerobic Bacillus Subtilis spores (ATCC 6633,
Biogenetics S.r.l., Padova, Italy), Gram-negative, aerobic Pseudomonas aeruginosa (ATCC 9027,
Biogenetics S.r.l.,Padova, Italy), Gram-positive, aerobic and anaerobic Staphylococcus aureus (ATCC 6538,
Biogenetics S.r.l., Padova, Italy), Gram-positive, aerobic and anaerobic Enterococcus hirae (ATCC 8043,
Biogenetics S.r.l., Padova, Italy). Bacterial strains were provided by the manufactures as lyophilized
pellet, containing a defined bacterial charge. After re-hydration in a defined Trypticase Soy Broth
(TSB) medium (Biomérieux Italia S.p.A., Firenze, Italy), bacteria were cultured until they reached a 107
logarithmic growth. After amplification, 16 × 107 CFU (Colony Forming Unit)/mL of each bacteria
strain were inoculated in 50 mL of TSB medium at a temperature of 37 ◦C for 24/48 h. This bacterial
suspension was then used to contaminate eight stainless steel device specimens (5.0 × 2.5 cm) for
at least two weeks at temperature of 37 ◦C under laminar flow hood. Eight negative controls were
performed with TBS alone, omitting bacteria solution. All the devices were previously sterilized in
an autoclave.
Crystal violet staining of biofilm populated biomaterial. One of the most common methods to
assess biofilm formation current relies on a 96 well microtiter plate assay, which usually involves a
colorimetric detection of the dye removed from the previously stained biofilm [16]. Crystal violet
is a basic protein dye that marks the surface negatively charged molecules (i.e., peptidoglycan) and
extracellular matrix of polysaccharides [17]. In order to avoid manipulation and artefacts due to the
detachment of bacteria and their biofilm, a crystal violet staining was directly applied to the surfaces
of material. After bacteria contamination, biomaterial was fixed in ice methanol for 5 min at room
temperature and then washed in H2O. A direct staining with aqueous solution (0.25% v/v) of crystal
violet (V5265, Sigma Aldrich, St Luis, MO, USA) was performed for 5 min at room temperature and,
after two washes in H2O, biomaterials were dried until the following steps.
Detection of biofilm by stereomicroscopic analysis. Using light stereomicroscopy (stereo zoom
Microscope for Large Fields AxioZoom V16 (Carl Zeiss Microscopy GmbH, Jena, Germany), Objective
Plan Neo Fluar Z 1X/0.25 FWD53.1 mm a qualitative analysis of the biofilm was performed.
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We acquired contiguous images applying the following parameters: magnification, 11.2×; field of view,
23.0 mm; resolution, 5.0 µm; depth of field, 0.5 µm. In order to acquire the whole surface of medical
devices, we used a mosaic technology in which Zeiss software ZEN Pro (Carl Zeiss Microscopy GmbH,
Jena, Germany) align, fuse, and stitch all contiguous images acquired by a semi-automatized table.
Measurement of biofilm populating material. The whole image obtained by a mosaic
reconstruction (with a ZEN Pro software) was analysed with ImageJ software [18]. Crystal violet color
was digitally separated using Ruifrok and Johnston’s color deconvolution algorithm implemented as
an NIH (National Institute of Health)-ImageJ macro. Code to implement this algorithm was obtained
from Image J plugin processes on Red/Green/Blue (RGB) images to create three 8-bit monochrome
images. The first represents crystal violet (color 1) and the other two images (colors 2 and 3) are the
background. This color deconvolution technique can separate combinations of two or three colors,
providing those colors sufficiently different in their red, green, or blue absorption features. This
deconvolution technique does not depend neither on the threshold nor is limited by the possibility
of overlapping absorption spectra. Orthonormal transformation of the original RGB image and color
deconvolution can be used to determine and quantify staining densities in the different areas [19,20].
Total area was calculated in square millimeters and reported as percentage of stained area.
Statistics. All results were presented in mean ± standard error of mean (Mean ± SEM). Student’s
t-test was used to assess the significant differences between contaminated and uncontaminated surfaces.
3. Results
Three-dimensional stereomicroscopy observations of biofilms showed the presence of a crystal
violet layer of positive cells developing onto the stainless steel material surface. Subsequently,
filamentous bacterial colonization occurred forming a highly complicated filamentous structure,
sparsely distributed and without any preferential attachment between rough and smooth surfaces
(Figure 1A–C). The specificity of staining is reported in Figure 1D showing an uncontaminated medical
device as a control (Figure 1D).
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Figure 1. Crystal violet staining (purple) (A): mosaic images acquired by the motorized stereo zoom 
microscope AxioZoom V.16 (Zeiss). Multiple images of the large samples were merged with ZEN Pro Figure 1. Crystal violet staining (purple) (A): mosaic images acquired by the motorized stereo zoom
microscope AxioZoom V.16 (Zeiss). Multiple images of the large samples were merged with ZEN Pro
software. Scale bars = 2000 µm (A) and 500 µm (B,C,D). Magnification = 11.2×; (B,C): magnification of
a representative area of the medical devices contaminated with bacteria strains; (D): negative control.
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In order to monitor bacteria grow, samples of contaminated TSB were analyzed both at time 0
and after 14 days of incubation. Starting from a total amount of 64 × 107 CFU/mL of four bacteria
strains (16 × 107 CFU/mL of each bacteria strain), after 14 days of contamination, we detected only 7.5
× 107 CFU/mL in the broth, suggesting that the majority (but not the totality) of bacteria adhered to
heat exchanger.
All contaminated and uncontaminated analyzed specimens of heat exchanger are reported in
Figure 2.
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Figure 2. Crystal violet staining (purple) of contaminated (left panel) and uncontaminated (right 
panel) specimens of heat exchanger. Images were acquired by the motorized stereo zoom microscope 
AxioZoom V.16 (Zeiss). Scale bar = 2000 μm. Magnification = 11.2×. 
NIH ImageJ software, implemented with a color deconvolution plugin, discriminated positive 
channel (in purple) from background colors (Figure 3). The quantification of the total positive area 
was performed using a binary conversion (black/white) and reported as ratio between positive 
area/total area with a percentage value (Table 1). Contaminated medical devices showed a positive 
area of 11.87 ± 2.13% in contrast with a significantly lower signal 0.3912 ± 0.12% of the negative 
controls (p < 0.001).  
Figure 2. Crystal violet staining (purple) of contaminated (left panel) and uncontaminated (right panel)
specimens of heat exchanger. Images were acquired by the motorized stereo zoom microscope
AxioZoom V.16 (Zeiss). Scale bar = 2000 µm. Magnification = 11.2×.
NIH ImageJ software, implemented with a color deconvolution plugin, discriminated positive
channel (in purple) from background colors (Figure 3). The quantification of the total positive area was
performed using a binary conversion (black/white) and reported as ratio between positive area/total
area with a percentage value (Table 1). Contaminated medical devices showed a positive area of
11.87 ± 2.13% in contrast with a significantly lower signal 0.3912 ± 0.12% of the negative controls
(p < 0.001).
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Magnification = 11.2×. 
Table 1. ImageJ quantification of the crystal violet positive area of eight specimens of contaminated 
heat exchanger (Samples 1–8). Results on negative controls were obtained by omitting bacteria strains 
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Our analytical procedure, based on a colorimetric assay associated with microscopic and digital 
analyses is rapid and a relatively convenient approach able to generate qualitative and semi-
quantitative data on biofilm formation on medical devices [21]. 
Figure 3. Upper panel: Mosaic images acquired by the motorized stereo zoom microscope AxioZoom
V.16 (Zeiss) of two different surfaces of medical devices. Multiple images of the large samples were
merged with ZEN Pro software. Lower panel: color deconvolution estimation of the original images
stained with crystal violet, in purple. Dotted line shows the area of interest. Scale bar = 5000 µm;
Magnification = 11.2×.
Table 1. ImageJ quantification of the crystal violet positive area of eight specimens of contaminated
heat exchanger (Samples 1–8).
Conta inated Sample Stained Area (Pixel2) mm2 Stained Area % CV Positive Area Average (%)
#1 68,469 79,801 11.2 10.388125
#2 26,411 30,782 4.15
#3 84,321 98,276 16.13
#4 59,147 68,936 11.21
#5 211,735 246,777 16.11
#6 57,876 67,455 12.135
#7 43,758 51 6.76
#8 35,147 40,964 5.41
Uncontaminated Sample Stained Area (Pixel2) mm2 Stained Area % CV Positive Area Average (%)
#9 120 3.93 0.55 0.39125
#10 200 3.2 0.45
#11 136 3.27 0.54
#12 150 2.79 0.45
#13 220 4.7 0.32
#14 164 3.74 0.24
#15 136 1.67 0.22
#16 250 2.67 0.36
Results on negative controls were obtained by omitting bacteria strains (Samples 9–16). Column 1 shows sample
identity numbers. Column 2 reported total crystal violet positive area expressed in pixel2. Column 3 represents
total crystal violet positive area expressed in mm2. Column 4 reports the ratio between crystal violet positive area
(expressed in mm2) and the heat exchanger total area (expressed as percentage). CV: crystal violet.
4. Discussion
Our analytical r , based on a colorimetric as ay ssociated with microscopic and
digit l analyses is r pid and a relatively co venient approach able to generate qu litative and
semi-quan tative data on biofilm formation on me ical devices [21].
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A staining method for microscopic observation of biofilms, as originally described by
J. W. Arnold [16], has the advantage to rapidly monitor biofilm evolution onto physical supports.
However, it does not provide a quantitative assessment of stained surface. Properly understanding and
quantifying biofilm colonization represents a critical point in the development of safer and functional
biomaterials. Our study, with a limitation of an in vitro investigation, combines qualitative and
semi-quantitative approaches in biofilm detection and localization by advanced stereomicroscopy
allowing a detailed structure–function analysis of biofilms. Moreover, mosaic technology can be
applied to the analysis of large surfaces in the range of square centimeters versus classic approaches
that are considering significantly smaller areas [22]. Our results, with the limitation of not providing
evidence of biofilm metabolism and architecture details, suggest how this platform could be introduced
during medical devices development such as during validation of antimicrobial treatments and during
biomaterial design. We are also confident that the crystal violet stained area is associated with bacteria
biofilm presence since the lack staining in control samples carried out by only TSB medium.
This study allowed a simple readout to verify the presence of contamination in medical device.
A further limitation of our study is the impossibility to verify the exact composition of biofilm. Crystal
violet protocol associated with a washing alcohol step in the original Gram staining procedure [23]
distinguishes Gram-positive from Gram-negative bacteria due to a significantly lower levels of
peptidoglycans in the latter that are weakly stained by crystal violet due to the alcohol washing.
In our protocol, due to the lack of alcohol, Gram-negative bacteria can still be visualized after Crystal
violet staining allowing us to detect at the same time both Gram-positive and Gram-negative bacteria.
Given that crystal violet staining is not able to identify bacteria strain as part of the biofilm,
our approach could be associated by in-depth molecular assays for a precise identification of the
involved strains. Further investigations shall be therefore needed in order to precisely correlate
CFU counts and/or PCR results with ImageJ analysis to translate our semi-quantitative read-out
into a more quantitative data. Moreover, a further optimization of our staining procedure with the
reduction of washing steps could avoid biofilm detachment facilitating the sampling for additional in
depth investigations.
While our study aims also to reduce the use of in vivo investigations, we aware also that animal
research is still relevant. At the same time, our method may be used to reduce these in vivo testing
within a predictive platform that could be further enriched by the proposed molecular assays.
5. Conclusions
The high specificity, low variability, high repeatability, and short duration of this analysis
could make this protocol as a complementary method in bacteria contamination monitoring and
an alternative easy, fast, and more affordable approach to detect biofilm formation.
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